Cargando…

Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study

SUMMARY: This study aimed to determine the interaction between baseline FRAX(®) fracture probability and romosozumab efficacy. Using an ITT approach, it was determined that the efficacy of romosozumab on clinical fracture, osteoporotic fracture, and major osteoporotic fracture is significantly great...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCloskey, E. V., Johansson, H., Harvey, N. C., Lorentzon, M., Shi, Y., Kanis, J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376732/ https://www.ncbi.nlm.nih.gov/pubmed/33537844 http://dx.doi.org/10.1007/s00198-020-05815-0

Ejemplares similares

Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures—A Post Hoc Analysis of the SCOOP Study
por: McCloskey, Eugene, et al.
Publicado: (2018)

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
por: Harvey, N. C., et al.
Publicado: (2015)

Potential Adverse Effect of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate
por: Zheng, Zhangan, et al.
Publicado: (2022)

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
por: McCloskey, E. V., et al.
Publicado: (2020)

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
por: Söreskog, E., et al.
Publicado: (2021)

Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment
por: Ye, Carrie, et al.
Publicado: (2023)

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
por: Lorentzon, Mattias, et al.
Publicado: (2022)

Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
por: Johansson, L., et al.
Publicado: (2022)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model
por: Kirilova, E., et al.
Publicado: (2020)

Romosozumab efficacy and safety in European patients enrolled in the FRAME trial
por: Langdahl, Bente, et al.
Publicado: (2022)

Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density
por: Jaiswal, Raju, et al.
Publicado: (2023)

A systematic review of hip fracture incidence and probability of fracture worldwide
por: Kanis, J. A., et al.
Publicado: (2012)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

FRAX™ and the assessment of fracture probability in men and women from the UK
por: Kanis, J. A., et al.
Publicado: (2008)

Fragility fractures in Europe: burden, management and opportunities
por: Borgström, Fredrik, et al.
Publicado: (2020)

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study
por: Geusens, Piet, et al.
Publicado: (2019)

Incidence of hip fracture in Saudi Arabia and the development of a FRAX model
por: Saleh, Yousef A. L., et al.
Publicado: (2022)

One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD
por: Larsson, B.A.M., et al.
Publicado: (2021)

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk
por: Dimai, Hans P., et al.
Publicado: (2022)

The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density
por: Larsson, B. A. M., et al.
Publicado: (2020)

Greater pQCT Calf Muscle Density Is Associated with Lower Fracture Risk, Independent of FRAX, Falls and BMD: A Meta‐Analysis in the Osteoporotic Fractures in Men (MrOS) Study
por: Harvey, Nicholas C., et al.
Publicado: (2022)

Epidemiology of hip fracture in Qatar and development of a country specific FRAX model
por: Abdulla, Nabeel, et al.
Publicado: (2022)

Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan
por: Lesnyak, O, et al.
Publicado: (2020)

Epidemiology of hip fracture and the development of FRAX in Ukraine
por: Povoroznyuk, VV, et al.
Publicado: (2017)

FRAX-based fracture probabilities in South Africa
por: Johansson, Helena, et al.
Publicado: (2021)

A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures
por: Schemitsch, Emil H., et al.
Publicado: (2020)

Reassessment Intervals for Transition From Low to High Fracture Risk Among Adults Older Than 50 Years
por: Leslie, William D., et al.
Publicado: (2020)

Epidemiology of hip fracture in Botswana
por: Kebaetse, M., et al.
Publicado: (2021)

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
por: McCloskey, E. V., et al.
Publicado: (2019)

A high incidence of vertebral fracture in women with breast cancer
por: Kanis, J A, et al.
Publicado: (1999)

T‐Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
por: Cosman, Felicia, et al.
Publicado: (2020)

Falls Predict Fractures Independently of FRAX Probability: A Meta‐Analysis of the Osteoporotic Fractures in Men (MrOS) Study
por: Harvey, Nicholas C, et al.
Publicado: (2017)

A surrogate FRAX model for the Kyrgyz Republic
por: Lesnyak, O., et al.
Publicado: (2020)

Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate
por: Lesnyak, O., et al.
Publicado: (2017)

Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models
por: Ramanau, H., et al.
Publicado: (2018)

Romosozumab for osteoporosis
Publicado: (2021)

Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada
por: Goeree, Ron, et al.
Publicado: (2022)

The effects of romosozumab combined with active vitamin D(3) on fracture healing in ovariectomized rats
por: Takase, Ryota, et al.
Publicado: (2022)

Osteoporosis in Europe: a compendium of country-specific reports
por: Willers, Carl, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pvknpeouk3ki0nlqjhgv2e2qha